Fatigue is an important clinical problem in patients with IBD, affecting nearly 50% of patients
in clinical remission and> 80% of those with active disease. The resulting decrease in …

Introduction Fatigue is a prevalent and potentially debilitating symptom that impacts the
health-related quality-of-life of individuals diagnosed with acute and chronic medical …

Patients with inflammatory bowel disease [IBD] increasingly use alternative and
complementary therapies, for which appropriate evidence is often lacking. It is estimated that …

Objective To determine whether anxiety and depression are associated with cognition in
multiple sclerosis (MS), and whether these associations are similar in other immune …

Objectives: To comprehensively review the scientific knowledge on the gut–brain axis.
Methods: Various publications on the gut–brain axis, until 31 July 2017, were screened …

Background Fatigue is the inability to achieve or maintain an expected work output resulting
from central or peripheral mechanisms. The prevalence of inflammatory bowel disease (IBD) …

Background People living with inflammatory bowel disease (IBD) are exposed to multiple
risk factors for cognitive impairment and frequently report cognitive difficulties. However, the …

Alterations in grey matter volume (GMV) and cortical thickness (CT) in Crohn's disease (CD)
patients has been previously documented. However, the findings are inconsistent, and not a …

Introduction Fatigue and malaise are commonly associated with a wide range of medical
conditions, including rheumatoid arthritis (RA). Evidence suggests that fatigue and malaise …

In recent years, the concept of disability has increasingly garnered attention as a crucial long-
term target of inflammatory bowel disease (IBD) management. The treatment paradigm has …